Effective obesity interventions could help more than 1.2 million adults in the UAE to overcome obesity, potentially contributing $51 billion to GDP by 2031, said a new report.
Eli Lilly and Company has announced that the US Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesity, or overweight with weight-related medical problems.
